Zusammenfassung
Die extrapulmonalen Auswirkungen der Lungenüberblähung betreffen Herzfunktion und Muskulatur von Patienten mit COPD. So ist ein Zusammenhang zwischen der Überblähung der Lunge bei COPD und der verminderten Füllung des Herzens in verschiedenen Untersuchungen gezeigt worden. Die verminderte kardiale Füllung führt wiederum zu einem verminderten Schlagvolumen und verstärkt möglicherweise die Belastungsintoleranz bei COPD. Interventionelle Maßnahmen zur Reduktion der Lungenüberblähung bewirken eine verbesserte kardiale Funktion. Durch die belastungsintoleranzinduzierte Dekonditionierung ist indirekt auch die Skelettmuskulatur von der Lungenüberblähung betroffen.
Abstract
Cardiac dysfunction and skeletal muscle dysfunction are extrapulmonary consequences of lung hyperinflation in chronic obstructive pulmonary disease (COPD). Several studies demonstrated that lung hyperinflation is related to an underfilling of the heart, which in turn leads to a reduced cardiac output and is associated with a further worsening of exercise intolerance in COPD. Interventional studies showed that cardiac function can be improved by interventional measures for reduction of lung hyperinflation. Skeletal muscle deconditioning due to exercise intolerance is an indirect consequence of lung hyperinflation in COPD.
Literatur
Wigh RE (1978) On defining microcardia: application in pulmonary emphysema. South Med J 71(2):150–154
Thurlbeck WM, Simon G (1978) Radiographic appearance of the chest in emphysema. AJR Am J Roentgenol 130(3):429–440
Hutsebaut J, Scano G, Garcia-Herreros P, Degre S, De Coster A, Sergysels R (1981) Hemodynamic characteristics in chronic obstructive lung disease as related to cardiac size. Respiration 41(1):25–32
Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK (1988) Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 138(2):350–354
Albert RK, Muramoto A, Caldwell J, Koepsell T, Butler J (1985) Increases in intrathoracic pressure do not explain the rise in left ventricular end-diastolic pressure that occurs during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 132(3):623–627
Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166(3):314–322
Criner GJ, Scharf SM, Falk JA, Gaughan JP, Sternberg AL, Patel NB et al (2007) Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 176(3):253–260
Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR et al (2008) Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 32(5):1275–1282
Lammi MR, Ciccolella D, Marchetti N, Kohler M, Criner GJ (2012) Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation. Eur Respir J 40(4):837–843
Travers J, Laveneziana P, Webb KA, Kesten S, O’Donnell DE (2007) Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med 101(9):2017–2024
Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M et al (2000) Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 162(2 Pt 1):670–675
Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M et al (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138(1):32–38
Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177(7):743–751
Watz H, Waschki B, Kirsten AM, Claussen M, Magnussen H (2008) Heart failure in chronic obstructive pulmonary disease (COPD). Dtsch Med Wochenschr 133(14):717–719
Watz H, Arzt M (2014) COPD and heart disease. Herz 39(1):53–57
Jorgensen K, Houltz E, Westfelt U, Nilsson F, Schersten H, Ricksten SE (2003) Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 124(5):1863–1870
Cuttica MJ, Colangelo LA, Shah SJ, Lima J, Kishi S, Arynchyn A et al (2015) Loss of lung health from young adulthood and cardiac phenotypes in middle age. Am J Respir Crit Care Med 192(1):76–85
Watz H (2015) The lungs and the heart. Am J Respir Crit Care Med 192(1):7–8
Jorgensen K, Muller MF, Nel J, Upton RN, Houltz E, Ricksten SE (2007) Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 131(4):1050–1057
Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA et al (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362(3):217–227
Grau M, Barr RG, Lima JA, Hoffman EA, Bluemke DA, Carr JJ et al (2013) Percent emphysema and right ventricular structure and function: the multi-ethnic study of atherosclerosis-lung and multi-ethnic study of atherosclerosis-right ventricle studies. Chest 144(1):136–144
Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D et al (2013) Impaired left ventricular filling in COPD and emphysema: Is it the heart or the lungs?: the multi-ethnic study of atherosclerosis COPD study. Chest 144(4):1143–1151
Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL et al (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109(7):785–802
Watz H (2016) Chronic obstructive pulmonary disease: When pulmonologists do something good for the heart. Am J Respir Crit Care Med 193(7):703–704
Stone IS, Barnes NC, James WY, Midwinter D, Boubertakh R, Follows R et al (2016) Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 193(7):717–726
Waschki B, Kirsten AM, Holz O, Mueller KC, Schaper M, Sack AL et al (2015) Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 192(3):295–306
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Watz gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von dem Autor durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
H. Worth, Fürth
Rights and permissions
About this article
Cite this article
Watz, H. Die extrapulmonalen Auswirkungen der Lungenüberblähung bei COPD. Pneumologe 14, 20–23 (2017). https://doi.org/10.1007/s10405-016-0086-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-016-0086-6
Schlüsselwörter
- Lungenerkrankung
- Chronische obstruktive Lungenerkrankung
- Herzfunktionstest
- Belastungsintoleranz
- Skelettmuskulatur